MIRM
MIRM
NASDAQ · Biotechnology

Mirum Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$107.16
+4.23 (+4.11%)
As of May 9, 1:18 AM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -37.7% upside
Low Target $36.90
Average Target $66.73
High Target $76.87
Current Price $107.16
Current
$107.16
Target
$66.73
$36.90 $66.73 avg $76.87
Scenario Analysis
Bear Case
$36.90
-65.6%
Low target
Base Case
$66.73
-37.7%
Avg target
Bull Case
$76.87
+-28.3%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$112.00
-4.3% from high
52-Week Low
$40.00
+167.9% from low
50-Day SMA
$87.61
+22.3% vs SMA
200-Day SMA
$68.12
+57.3% vs SMA
RSI (14)
56.6
Neutral
Target vs 52W High
$66.73
-40.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%